Skip to main content

4 articles related to "Deep Molecular Response Dmr"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 16 Nov 2023

18 months follow-up of deep molecular response 4.5 (MR4.5) with nilotinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a prospective, multi-center study in China

in Hematology

Bingbing Wen
Yuming Zhang
Haiqing Lin
Jin Lou
Chuangqing Tu
Yirong Jiang
Xiaolian Liu
Yan Chen
Huiqing He
Zelin Liu

Frontiers in Medicine

doi 10.3389/fmed.2023.1267512

2,795 views

Systematic Review

Published on 14 May 2019

Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia With Losing Major Molecular Response as a Definition for Molecular Relapse: A Systematic Review and Meta-Analysis

in Hematologic Malignancies

Kang-kang Chen
Tai-feng Du
Pei-sheng Xiong
Guan-hua Fan
Wei Yang

Frontiers in Oncology

doi 10.3389/fonc.2019.00372

10,539 views
41 citations

Systematic Review

Published on 10 Feb 2022

Impact of BCR-ABL1 Transcript Type on Outcome in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors: A Pairwise and Bayesian Network Meta-Analysis

in Hematologic Malignancies

Kangkang Chen
Yingying Ruan
Kewei Tian
Peisheng Xiong
Nan Xia
Jin Li
Wen Huang
Feiyan Cao
Qifeng Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.841546

5,107 views
9 citations

Original Research

Published on 02 May 2023

Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China

in Hematologic Malignancies

Fang Cheng
Guolin Yuan
Qiang Li
Zheng Cui
Weiming Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1172910

4,839 views
13 citations